Coalition Of Drug Makers, Insurers, PBMs Unveil Drug Pricing Platform

A coalition of insurers, drug makers and pharmacy benefit managers unveiled Wednesday (May 16) a slate of proposals they predict will lower drug prices, including pushing FDA to issue guidelines on preapproval communication between industry and payers, creating a priority review voucher for certain generics coupled with expedited FDA review of these drugs, exempting value-based arrangements from price reporting requirements, shielding value-based arrangements from anti-kickback and Stark laws, and encouraging data sharing. The coalition touts the proposals as the first...